{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:18:53Z","timestamp":1792603133199,"version":"4.5.0"},"reference-count":71,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mast cells play a critical role in the pathogenesis of allergic asthma. Histamine is a central mediator released from mast cells through allergic reactions. Histamine plays a role in airway obstruction via smooth muscle contraction, bronchial secretion, and airway mucosal edema. However, previous clinical trials of H1 receptor antagonists (H1RAs) as a treatment for asthma were not successful. In recent years, type 2 innate immunity has been demonstrated to be involved in allergic airway inflammation. Allergic asthma is defined by IgE antibody-mediated mast cell degranulation, while group 2 innate lymphoid cells (ILC2) induce eosinophilic inflammation in nonallergic asthma without allergen-specific IgE. Anti-IgE therapy has demonstrated prominent efficacy in the treatment of severe allergic asthmatics sensitized with specific perennial allergens. Furthermore, recent trials of specific cytokine antagonists indicated that these antagonists were effective in only some subtypes of asthma. Accordingly, H1RAs may show significant clinical efficacy for some subtypes of allergic asthma in which histamine is deeply associated with the pathophysiology.<\/jats:p>","DOI":"10.3390\/ijms20071733","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T11:54:52Z","timestamp":1554724492000},"page":"1733","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["The Role of Histamine in the Pathophysiology of Asthma and the Clinical Efficacy of Antihistamines in Asthma Therapy"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-7930","authenticated-orcid":false,"given":"Kohei","family":"Yamauchi","sequence":"first","affiliation":[{"name":"Division of Respirology, Department of Internal Medicine, Takizawa Central Hospital, Takizawa 020-0664, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Ogasawara","sequence":"additional","affiliation":[{"name":"Division of Bioregulatory Pharmacology, Department of Pharmacology, Iwate Medical University, Morioka 028-3694, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1476-5381.1952.tb00712.x","article-title":"The nature of the pulmonary receptors excited by antihistamines","volume":"7","author":"Jones","year":"1952","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1152\/ajplegacy.1975.229.4.1008","article-title":"Histamine H1- and H2-receptors in pulmonary and systemic vasculature of the dog","volume":"229","author":"Tucker","year":"1975","journal-title":"Am. J. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0014-2999(89)90212-4","article-title":"Inhibitory histamine H3-receptors on cholinergic nerves in human airways","volume":"163","author":"Ichinose","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2018.08.028","article-title":"Histamine H4 receptor mediates chemotaxis of human lung mast cells","volume":"837","author":"Kay","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1172\/JCI101765","article-title":"The effect of antihistamine substances and other drugs on histamine bronchoconstriction in asthmatic subjects","volume":"25","author":"Curry","year":"1946","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI109063","article-title":"Comparative responses of tracheal spirals and parenchymal strips to histamine and carbachol in vitro","volume":"61","author":"Drazen","year":"1978","journal-title":"J. Clin. Investig."},{"key":"ref_7","first-page":"175","article-title":"Characterization of H1- and H2-receptor function in pulmonary and systemic circulations of sheep","volume":"53","author":"Ahmed","year":"1982","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.ph.41.030179.002101","article-title":"Control of mucus secretion and ion transport in airways","volume":"41","author":"Nadel","year":"1979","journal-title":"Annu. Rev. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0091-6749(05)80223-4","article-title":"The role of histamine in allergic diseases","volume":"86","author":"White","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI112937","article-title":"Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness","volume":"79","author":"Casale","year":"1987","journal-title":"J. Clin. Investig."},{"key":"ref_11","first-page":"1000","article-title":"Mast cells in bronchoalveolar lumen of patients with bronchial asthma","volume":"129","author":"Tomioka","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1113\/jphysiol.1919.sp001837","article-title":"Histamine shock","volume":"52","author":"Dale","year":"1919","journal-title":"J. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4049\/jimmunol.108.2.513","article-title":"Release of histamine and slow reacting substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells","volume":"108","author":"Ishizaka","year":"1972","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI101764","article-title":"The action of histamine on the respiratory tract in normal and asthmatic subjects","volume":"25","author":"Curry","year":"1946","journal-title":"J. Clin. Investig."},{"key":"ref_15","first-page":"409","article-title":"The pathophysiology of asthma","volume":"121","author":"Hogg","year":"1979","journal-title":"Can. Med. Assoc. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/ajrccm\/136.2.369","article-title":"The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5\u2032 monophosphate in atopic asthma","volume":"136","author":"Rafferty","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_17","first-page":"377","article-title":"Regulation of gene expression of l-histidine decarboxylase and histamine N-methyl-transferase, and its relevance to the pathogenesis of bronchial asthma","volume":"54","author":"Yamauchi","year":"1996","journal-title":"Nihon Rinsho"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0091-6749(95)70228-8","article-title":"Histamine N-methyltransferase inhibitor potentiates histamine- and antigen-induced airway microvascular leakage in guinea pigs","volume":"96","author":"Sekizawa","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_19","first-page":"L342","article-title":"Structure and function of human histamine N-methyltransferase: Critical enzyme in histamine metabolism in airway","volume":"267","author":"Yamauchi","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1165\/rcmb.2014-0493OC","article-title":"Genetic Variation along the Histamine Pathway in Children with Allergic versus Nonallergic Asthma","volume":"53","author":"Anvari","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.01873","article-title":"The Role of Histamine and histamine receptors in Mast cell-mediated allergy and inflammation: The Hunt for New therapeutic Targets","volume":"9","author":"Thangam","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1254\/jphs.FM0070294","article-title":"Progress in allergy signal research on mast cells: The role of histamine in immunological and cardiovascular disease and the transporting system of histamine in the cell","volume":"106","author":"Ohtsu","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1254\/jphs.FMJ06001X6","article-title":"Recent advances in Molecular Pharmacology of the histamine systems: Organic cation Transporters as a Histamine transporter and Histamine Metabolism","volume":"101","author":"Ogasawara","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pflugers Arch."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/164_2016_13","article-title":"Histamine Clearance through Polyspecific Transporters in the Brain","volume":"241","author":"Yoshikawa","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/MCB.21.13.4188-4196.2001","article-title":"Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3\/Slc22a3-deficient mice","volume":"21","author":"Zwart","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/jcbfm.2012.92","article-title":"Targeted disruption of organic cation transporter 3(Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells","volume":"32","author":"Zhu","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1248\/yakushi.131.185","article-title":"Roles of histamine in the pathogenesis of bronchial asthma and reevaluation of the clinical usefulness of antihistamines","volume":"131","author":"Yamauchi","year":"2011","journal-title":"Yakugaku Zasshi"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1254\/jphs.09331SC","article-title":"Functional analysis of human Organic cation Transporter OCT3(SLC22A3) polymorphisms","volume":"113","author":"Sakata","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/mol.118.112482","article-title":"Organic Cation Transporter 3 facilitates Fetal Exposure to Metformin during Pregnancy","volume":"94","author":"Lee","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.arcmed.2017.03.010","article-title":"Polymorphic Variants rs3088442 and rs2292334 in the Organic cation Transporter 3(OCT3) gene and Susceptibility Against Type 2 Diabetes: Role of their Interaction","volume":"48","author":"Mahrooz","year":"2017","journal-title":"Arch. Med. Res."},{"key":"ref_32","first-page":"250","article-title":"Association between the synonymous variant organic cation transporter 3(OCT3)-1233>A and the glycemic response following metformin therapy in patients with type 2 diabetes","volume":"20","author":"Mahrooz","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/1735-1995.192508","article-title":"Allele frequency and genotype distribution of a common variant in the 3\u2032-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin","volume":"21","author":"Mahrooz","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-16-0347","article-title":"Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients","volume":"175","author":"Zaharenko","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/mol.114.096776","article-title":"Targeted disruption of organic cation transporter 3 attenuates the pharmacological response to metformin","volume":"88","author":"Chen","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_36","first-page":"110","article-title":"Genetics and epigenetic regulation of the organic cation transporter 3, SLC22A3","volume":"13","author":"Chen","year":"2013","journal-title":"Pharm. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1530-0277.2006.00215.x","article-title":"Association between gene polymorphisms of SLA22A3 and methamphetamine use disorder","volume":"30","author":"Aoyama","year":"2006","journal-title":"Alchol. Clin. Exp. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/all.13227","article-title":"Histamine receptor 2 modified iNKT cell activity within the inflamed lung","volume":"72","author":"Ferstl","year":"2017","journal-title":"Allergy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20050195","article-title":"Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels","volume":"202","author":"Schneider","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_40","first-page":"615","article-title":"Antihistamines in bronchial asthma","volume":"42","author":"Herxheimer","year":"1949","journal-title":"Proc. R. Soc. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.alit.2016.11.001","article-title":"Japanese Society of Allergology. Japanese guidelines for allergic rhinitis 2017","volume":"66","author":"Okubo","year":"2017","journal-title":"Allergol. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMcp1412282","article-title":"Clinical practice. Allergic rhinitis","volume":"372","author":"Wheatley","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"ref_44","unstructured":"(2019, February 03). The Global Initiative for Asthma; Global Strategy for Asthma Management and Prevention (2018 Update). Available online: https:\/\/ginasthma.org\/about-us\/."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.155.6.9196086","article-title":"Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics","volume":"155","author":"Roquet","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/35096564","article-title":"Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors","volume":"413","author":"Jutel","year":"2001","journal-title":"Nature"},{"key":"ref_47","first-page":"344","article-title":"Purified protein derivate of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profiles of cytokine production","volume":"88","author":"Mastromauro","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant Th2-like bronchoalveolar T lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(01)02663-1","article-title":"Mice lacking histidine decarboxylase exhibit abnormal mast cells","volume":"502","author":"Ohtsu","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.200206-619OC","article-title":"Disruption of L-histidine decarboxylase reduces airway eosinophilia but not hyperresponsiveness","volume":"167","author":"Koarai","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1081\/RRS-120014612","article-title":"Identification of a histamine H4 receptor on human eosinophils\u2014Role in eosinophil chemotaxis","volume":"22","author":"Alpert","year":"2002","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1067\/mai.2002.125977","article-title":"The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis","volume":"110","author":"Hori","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2332\/allergolint.O-08-547","article-title":"Enhanced goblet cell hyperplasia in HDC knockout mice with allergic airway inflammation","volume":"58","author":"Yamauchi","year":"2009","journal-title":"Allergol. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1073\/pnas.081510898","article-title":"Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma","volume":"98","author":"Nakanishi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/ajrccm\/146.3.768","article-title":"Tumor necrosis factor-\u03b1 and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgEdependent stimulation","volume":"146","author":"Gosset","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jaci.2005.08.059","article-title":"Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo","volume":"116","author":"Busse","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12540","article-title":"Allergic airway inflammation: Key players beyond the Th2 cell pathway","volume":"278","author":"Hirose","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.chest.2016.10.038","article-title":"An Update on Lymphocyte Subtypes in Asthma and Airway Disease","volume":"151","author":"Moldaver","year":"2017","journal-title":"Chest"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/imm.12153","article-title":"Group 2 innate lymphoid cells in lung inflammation","volume":"140","author":"Li","year":"2013","journal-title":"Immunology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/ACI.0000000000000090","article-title":"Type-2 innate lymphoid cells in human allergic disease","volume":"14","author":"Barlow","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ACI.0000000000000346","article-title":"Asthma guidelines: The Global Initiative for Asthma in relation to national guidelines","volume":"17","author":"Becker","year":"2017","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.alit.2016.12.005","article-title":"Japanese Society of Allergology Japanese guidelines for adult asthma 2017","volume":"66","author":"Ichinose","year":"2017","journal-title":"Allergol. Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2332\/allergolint.08-OA-0004","article-title":"Analysis of the comorbidity of bronchial asthma and allergic rhinitis by questionnaire in 10,009 patients","volume":"58","author":"Yamauchi","year":"2009","journal-title":"Allergol. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.bjp.0705530","article-title":"Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor","volume":"140","author":"Buckland","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000285088","article-title":"Does the histamine H4 receptor have a pro- or anti-inflammatory role in murine bronchial asthma?","volume":"85","author":"Neumann","year":"2010","journal-title":"Pharmacology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.102.046581","article-title":"Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells","volume":"305","author":"Hofstra","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.4049\/jimmunol.176.11.7062","article-title":"The Histamine H4 Receptor Mediates Allergic Airway Inflammation by Regulating the Activation of CD4+ T Cells","volume":"176","author":"Dunford","year":"2006","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1465-9921-11-86","article-title":"Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines","volume":"11","author":"Cowden","year":"2010","journal-title":"Respir. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.113.211714","article-title":"Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979","volume":"349","author":"Thurmond","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.anai.2018.08.001","article-title":"A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma","volume":"121","author":"Kollmeier","year":"2018","journal-title":"Ann. Allergy Asthma Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/7\/1733\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:43:39Z","timestamp":1760186619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/7\/1733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["ijms20071733"],"URL":"https:\/\/doi.org\/10.3390\/ijms20071733","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]}}}